aTYR PHARMA ATYR
NASDAQ ATYR
$0.38 +0.01 (+4.13%)
As of: Sep 21, 2026 · 10:48 AM EDT

aTYR PHARMA (ATYR) Prepaid Assets (2014 - 2026)

aTYR PHARMA's (ATYR) quarterly Prepaid Assets came in at $518000.0 in Q2 2026, down 92.21% on a YoY basis from $6.6 million in Q2 2025, and down 11.6% quarter-over-quarter from $586000.0 in Q1 2026.

Analysis

aTYR PHARMA (ATYR) Prepaid Assets (2014 - 2026) Analysis & Trends

aTYR PHARMA (ATYR) has reported Prepaid Assets for 13 consecutive years, with $518000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets fell 92.21% year-over-year to $518000.0; the trailing twelve-month figure through Jun 2026 stood at $518000.0 (down 92.21% YoY), and the FY2025 full-year result was $677000.0, down 91.63% from the prior year.
  • Prepaid Assets retreated to $518000.0 in Q2 2026 per ATYR's latest filing, from $586000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $10.2 million in Q2 2024 and bottomed at $518000.0 in Q2 2026.
  • Historically, Prepaid Assets has averaged $4.7 million across 5 years, with a median of $4.2 million in 2022.
  • The sharpest annual moves came in 2024 and 2026: Prepaid Assets soared 238.62% in 2024, then plunged 92.21% in 2026.
  • Over 5 years, Prepaid Assets stood at $2.9 million in 2022, then slipped by 18.98% to $2.4 million in 2023, then jumped by 238.62% to $8.1 million in 2024, then plunged by 91.63% to $677000.0 in 2025, then dropped by 23.49% to $518000.0 in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $518000.0, $586000.0, and $677000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 aTYR PHARMA 35.31 Mn -22.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 518,000.00
Mar 31, 2026 586,000.00
Dec 31, 2025 677,000.00
Sep 30, 2025 1.77 Mn
Jun 30, 2025 6.65 Mn
Mar 31, 2025 5.93 Mn
Dec 31, 2024 8.09 Mn
Sep 30, 2024 8.50 Mn
Jun 30, 2024 10.19 Mn
Mar 31, 2024 9.94 Mn
Dec 31, 2023 2.39 Mn
Sep 30, 2023 3.08 Mn
Jun 30, 2023 4.56 Mn
Mar 31, 2023 3.44 Mn
Dec 31, 2022 2.95 Mn
Sep 30, 2022 6.39 Mn
Jun 30, 2022 4.38 Mn
Mar 31, 2022 4.03 Mn
Dec 31, 2021 5.22 Mn
Sep 30, 2021 5.09 Mn